← Leaderboards
Mouhsin Shafi
Beth Israel Deaconess Medical Center
$7,359,533
Attributed
$8,528,130
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.6M · FY2018–25$2M$1.5M$1M$500K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$8,528,130 · 4
By mechanism
R01$7,884,110 · 3
P01$644,020 · 1
Top collaborators
- Suvranu De3 shared
- Ernest Dennis Gomez3 shared
Most similar at Beth Israel Deaconess Medical Center
Same institution · by research overlap
- Gottfried Schlaug$12,613,164
- Sandeep Kumar$2,876,556
- Daniel Z. Press$4,768,036
- Jeffrey M Hausdorff$3,580,148
- Stephanie Buss$920,718
Others in their field
Other Emerging Leaders on “Participant”
- Chanza Baytop · Westat, Inc.$271,217,917
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Beth Baseler · Leidos Biomedical Research, Inc.$117,364,154
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$102,389,765
- Scott Topper · Broad Institute, Inc.$101,052,360
- Paul F Gallagher · Woods Hole Oceanographic Institution$92,619,872
Research focus
ParticipantBrainFunctional DisorderElectroencephalographyResponseMotorNeuropsychologyMagnetic Resonance ImagingAlzheimer&AposCognitiveCognitionDoseRestCostFutureRandomizedStructurePerformanceAffectHourPharmaceutical PreparationsResearch PersonnelCognitive FunctionDementia
Grant awards (16)
Enhancing robotic head and neck surgical skills using stimulated simulation$580,856
R01 · FY2025 · EB
Enhancing robotic head and neck surgical skills using stimulated simulation$553,441
R01 · FY2024 · EB
Enhancing robotic head and neck surgical skills using stimulated simulation$618,599
R01 · FY2023 · EB
Treating hyperexcitability in Alzheimer's disease with levetiracetam to improve brain function and cognition$598,718
R01 · FY2023 · AG · contact PI
Treating hyperexcitability in Alzheimer's disease with levetiracetam to improve brain function and cognition$637,458
R01 · FY2022 · AG · contact PI
Reliability of Repetitive TMS-induced Modulation of Cortical Excitability$570,244
R01 · FY2022 · MH · contact PI
Characterizing the Relationship between Brain Electrophysiology, Delirium, and Cognitive Decline$344,971
P01 · FY2022 · AG · contact PI
Treating hyperexcitability in AlzheimerâÃÂÃÂs disease with levetiracetam to improve brain function and cognition$586,322
R01 · FY2021 · AG · contact PI
Reliability of Repetitive TMS-induced Modulation of Cortical Excitability$536,814
R01 · FY2021 · MH · contact PI
Treating hyperexcitability in Alzheimerâs disease with levetiracetam to improve brain function and cognition$584,852
R01 · FY2020 · AG · contact PI
Reliability of Repetitive TMS-induced Modulation of Cortical Excitability$521,377
R01 · FY2020 · MH · contact PI
Treating hyperexcitability in Alzheimerâs disease with levetiracetam to improve brain function and cognition$571,143
R01 · FY2019 · AG · contact PI
Reliability of Repetitive TMS-induced Modulation of Cortical Excitability$539,802
R01 · FY2019 · MH · contact PI
Reliability of Repetitive TMS-induced Modulation of Cortical Excitability$548,725
R01 · FY2018 · MH · contact PI
Repetitive TMS-induced modulation of cortical excitability in AD$435,759
R01 · FY2018 · MH · contact PI
Characterizing the Relationship between Brain Electrophysiology, Delirium, and Cognitive Decline$299,049
P01 · FY2018 · AG · contact PI